Zobrazeno 1 - 10
of 500
pro vyhledávání: '"A. A. Kachanova"'
Autor:
l. V. Fedina, i. N. Sychev, K. V. Mirzaev, A. V. Vardanyan, S. V. Glagolev, A. A. Kachanova, P. O. Bochkov, R. V. Shevchenko, S. N. Tuchkova, I. V. Sychev, S. P. Abdullaev, D A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 1, Pp 19-26 (2024)
Aim. The aim of our study was to investigate the influence of polymorphic markers of CYP3A4*22 CYP3A4*22 (c.522-191C>T, rs35599367), CYP3A5*3 (c.219237A>G, rs776746), ABCB1 rs1045642 (c.3435T>C) and rs4148738 (c.2692-2236C>T) genes on the plasma conc
Externí odkaz:
https://doaj.org/article/895693a579cb4ad08184d9190f32a514
Autor:
D. A. Sychev, K. B. Mirzaev, M. S. Cherniaeva, N. V. Shakhgildyan, Sh. P. Abdullaev, N. P. Denisenko, Zh. A. Sozaeva, A. A. Kachanova, V. R. Shastina, S. V. Gorbatenkova
Publikováno v:
Acta Biomedica Scientifica, Vol 8, Iss 6, Pp 51-80 (2024)
Background. The use of P-glycoprotein (P-gp) inhibitors and carriage of certain ABCB1 polymorphisms can lead to increased concentrations of rivaroxaban and the development of bleeding.The aim of the study. To study the features of drug-drug interacti
Externí odkaz:
https://doaj.org/article/80ceb717f6c74d60a892134e49db667e
Autor:
Sh. P. Abdullaev, N. P. Denisenko, I. I. Temirbulatov, A. A. Kachanova, S. N. Tuchkova, E. V. Mikhaylenko, A. V. Kryukov, T. T. Valiev, K. B. Mirzaev, D. A. Sychev
Publikováno v:
Acta Biomedica Scientifica, Vol 8, Iss 6, Pp 23-30 (2024)
Background. There is a mounting evidence in the scientific literature that susceptibility to SARS-CoV-2 infection could vary. The severity of COVID-19 symptoms can range from asymptomatic to severe respiratory failure, requiring prolonged artificial
Externí odkaz:
https://doaj.org/article/7c25c2af93a1434da4254760586fc038
Autor:
I. V. Sychev, N. P. Denisenko, A. A. Kachanova, A. V. Lapshtaeva, Sh. P. Abdullaev, L. N. Goncharova, K. B. Mirzaev, D. A. Sychev
Publikováno v:
Безопасность и риск фармакотерапии, Vol 11, Iss 2, Pp 231-240 (2023)
Angiotensin-converting enzyme inhibitors (ACEIs) are among the most prescribed and effective medicinal products for the treatment of several cardiovascular diseases. According to a number of studies, 30% of patients taking ACEIs develop adverse drug
Externí odkaz:
https://doaj.org/article/612fe468ef6f4c729519954a14d7b41a
Autor:
L. V. Fedina, I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, D. A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 6, Pp 624-629 (2023)
Aim. To investigate the effect of ABCB1 gene carriage and interdrug interactions on apixaban pharmacokinetics and clinical outcomes in patients with atrial fibrillation and deep vein thrombosis.Material and methods. Patients hospitalized at Yudin Sta
Externí odkaz:
https://doaj.org/article/547d7b56152449b99e64946f0dcd6d76
Autor:
N. P. Denisenko, Sh. P. Abdullaev, K. A. Akmalova, Zh. A. Sozaeva, A. A. Kachanova, M. S-Kh. Sozaeva, L. Z. Bolieva, E. A. Grishina, D. A. Sychev
Publikováno v:
Современная ревматология, Vol 16, Iss 1, Pp 60-67 (2022)
The efficacy and safety of non-steroidal anti-inflammatory drugs (NSAIDs) may be determined by the polymorphic nature of the CYP2C8, PTGS1 and PTGS2 genes.Objective: to analyze the nature of the distribution of CYP2C8*3 (rs10509681), CYP2C8*3 (rs1157
Externí odkaz:
https://doaj.org/article/e05ca74d86d449cba880c648b464c477
Autor:
D. V. Ivaschenko, N. I. Buromskaya, P. V. Shimanov, R. V. Deitsch, M. I. Nastovich, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Y. S. Shevchenko, D. A. Sychev
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 39-49 (2021)
Introduction. Pharmacokinetic genetic factors are prognostically relevant when prescribing antipsychotics to adult patients. Currently, there is a dearth of research on adolescents with an acute psychotic episode. Aim. To identify possible associatio
Externí odkaz:
https://doaj.org/article/05510408aa9d4b549d7c7efb64bdbff9
Autor:
T. E. Morozova, D. A. Shatsky, N. V. Shikh, E. V. Shikh, T. B. Andrushchyshina, M. V. Lukina, A. A. Kachanova, Z. A. Sozaeva, G. N. Shuev, N. P. Denisenko, E. А. Grishina, D. A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 5, Pp 719-723 (2021)
Aim. Evaluation of the effect of polymorphisms of the CYP2D6, CYP2C8 genes on the efficacy and safety of postoperative analgesia with ketoprofen in patients with coronary artery disease after cardiac surgery.Material and methods. The study included 9
Externí odkaz:
https://doaj.org/article/315eddefede3447a9f0ce3236f933058
Autor:
T. E. Morozova, D. A. Shatsky, N. V. Shikh, E. V. Shikh, T. B. Andrushchyshina, M. V. Lukina, A. A. Kachanova, Zh. A. Sozaeva, G. N. Shuev, N. P. Denisenko, E. A. Grishina, D. A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 4, Pp 570-575 (2021)
Aim. The aim of the study was to evaluate the efficacy and safety of ketoprofen as an analgesic therapy in patients with CYP2C9*2 (430C>T) rs179985 and CYP2C9*3 (1075A>C) rs1057910 gene polymorphisms after cardiac surgery.Material and methods. The st
Externí odkaz:
https://doaj.org/article/544a1dde8efd4fd1af17a485b0e980f3
Autor:
D. V. Ivaschenko, L. V. Fedina, N. I. Buromskaya, P. V. Shimanov, R. V. Deitsch, M. I. Nastovich, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Y. S. Shevchenko, D. A. Sychev
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 78-88 (2021)
Introduction. Antipsychotics are the main drugs for treatment of schizophrenia spectrum disorders. Pharmacodynamic genetic factors are being actively studied to improve the accuracy of antipsychotic selection based on pharmacogenetic testing. Purpose
Externí odkaz:
https://doaj.org/article/482e62160ac840f6a9c671c232303e4f